cytk stock
Trending on Tuesday, May 5, 2026
Peak Traffic
200+
Related News
3
Country
US
Related News
Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy
Source: Cytokinetics |
Read article →
Cytokinetics drug Myqorzo meets twin efficacy goals in study of genetic heart disease
Source: STAT |
Read article →
Cytokinetics' Myqorzo succeeds in landmark cardiomyopathy trial
Source: Fierce Pharma |
Read article →